Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 1.72M | $54.0M | 10.85% | -- | 2026-06-30 |
| Casdin Capital, LLC | 1.55M | $48.0M | 9.76% | +125.0K | 2026-06-30 |
| Redmile Group, LLC | 1.41M | $44.0M | 8.92% | -47.4K | 2026-06-30 |
| RTW INVESTMENTS, LP | 1.36M | $42.0M | 8.61% | -- | 2026-06-30 |
| EcoR1 Capital, LLC | 1.27M | $39.0M | 8.03% | -- | 2026-06-30 |
| BlackRock, Inc. | 1.06M | $33.0M | 6.68% | +52.9K | 2026-06-30 |
| BAKER BROS. ADVISORS LP | 991.7K | $31.0M | 6.26% | -- | 2026-06-30 |
| Balyasny Asset Management L.P. | 818.7K | $25.0M | 5.17% | +100.3K | 2026-06-30 |
| Trails Edge Capital Partners, LP | 714.9K | $22.0M | 4.52% | -67.9K | 2026-06-30 |
| TORONTO DOMINION BANK | 681.3K | $21.0M | 4.30% | -- | 2026-06-30 |
